Steven Le Gouill Selected Research

Steven Le Gouill Research Topics

Disease

28	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 08/2010
21	Lymphoma (Lymphomas) 01/2022 - 03/2002
19	Neoplasms (Cancer) 01/2022 - 09/2005
17	Multiple Myeloma 01/2021 - 11/2004
14	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2009
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022 - 03/2002
11	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 04/2011
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2013
8	Disease Progression 01/2022 - 10/2007
6	Neutropenia 01/2022 - 06/2016
5	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 12/2009
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2009
4	Infections 01/2022 - 01/2017
4	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2021 - 01/2010
4	Residual Neoplasm 01/2021 - 01/2019
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 06/2010
3	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2020
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 01/2019
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 11/2009
3	Genetic Translocation (Chromosomal Translocation) 04/2015 - 09/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 04/2018
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 01/2017
2	Leukemia 01/2019 - 11/2004
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2016 - 01/2013
2	Lymphocytosis 04/2015 - 08/2010
1	Macrophage Activation Syndrome 10/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Enterocolitis 01/2022
1	Fever (Fevers) 01/2022
1	Fever of Unknown Origin 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Stomatitis 01/2022

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 01/2022 - 02/2010
10	Lenalidomide (CC 5013)FDA Link 01/2022 - 12/2004
8	obinutuzumabIBA 01/2022 - 10/2018
7	Bendamustine Hydrochloride FDA Link 01/2022 - 01/2013
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 06/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 07/2013
5	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 12/2005
5	venetoclaxIBA 01/2021 - 04/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 07/2012
4	Biological ProductsIBA 01/2022 - 04/2015
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 04/2015
4	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 04/2011
3	Chimeric Antigen ReceptorsIBA 10/2022 - 11/2020
3	tisagenlecleucelIBA 01/2022 - 11/2020
3	ibrutinibIBA 01/2022 - 04/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2020
3	CytokinesIBA 01/2021 - 09/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2017
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2017
3	Monoclonal AntibodiesIBA 06/2019 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2018 - 09/2014
3	Cyclin D1IBA 04/2015 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
2	axicabtagene ciloleucelIBA 07/2021 - 11/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 11/2011
2	Busulfan (Busulfex)FDA Link 01/2020 - 11/2011
2	purineIBA 01/2020 - 01/2016
2	acalabrutinibIBA 11/2019 - 01/2018
2	Proteasome InhibitorsIBA 06/2019 - 06/2019
2	flt3 ligand protein (flt3 ligand)IBA 01/2019 - 01/2019
2	Clofarabine (Clolar)FDA Link 01/2019 - 09/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 11/2009
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 06/2015
2	Janus Kinase InhibitorsIBA 07/2017 - 01/2009
2	fludarabineIBA 01/2016 - 11/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 01/2014 - 04/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013 - 01/2009
2	InterferonsIBA 07/2013 - 08/2011
2	ABT-737IBA 10/2011 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 09/2005 - 11/2004
2	CaspasesIBA 09/2005 - 09/2005
1	NivolumabIBA 01/2022
1	atezolizumabIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	GlobulinsIBA 01/2022
1	Biological FactorsIBA 01/2021
1	pirtobrutinibIBA 01/2021
1	OligonucleotidesIBA 01/2021
1	KIR ReceptorsIBA 01/2021
1	LigandsIBA 01/2021
1	temsirolimus FDA Link 08/2020
1	Histones (Histone)IBA 01/2020
1	tazemetostatIBA 01/2020

Therapy/Procedure

38	Therapeutics 10/2022 - 03/2002
23	Stem Cell Transplantation 01/2022 - 03/2002
19	Drug Therapy (Chemotherapy) 01/2022 - 10/2007
9	Transplantation 01/2022 - 12/2009
4	Induction Chemotherapy 01/2022 - 01/2017
4	Radioimmunotherapy 01/2017 - 03/2008
3	Immunotherapy 10/2021 - 01/2018
3	Hematopoietic Stem Cell Transplantation 01/2020 - 06/2010
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2018
2	Autologous Transplantation 01/2021 - 05/2019
2	BEAM regimen 01/2020 - 04/2011
2	Cell Transplantation 05/2019 - 02/2015
1	Injections 01/2022